Teva sues Synthon over generic Multiple Sclerosis drug

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Teva sues Synthon over generic Multiple Sclerosis drug

Postby MSUK » Thu Apr 05, 2012 12:03 am


Teva Pharmaceutical Industries Ltd. (TEVA) sued Synthon BV for infringing seven patents in planning to sell a generic version of the multiple sclerosis drug Copaxone before Teva’s patents expire.

Teva, based in Petach Tikva, Israel, said it licensed the patents from Yeda Research & Development Co., according to the lawsuit filed yesterday in federal court in New York.

Copaxone, used to reduce the frequency of relapses in multiple sclerosis patients, generated sales (TEVA) of $3.9 billion in 2011. Synthon filed an application with the U.S. Food and Drug Administration seeking approval of a generic version of the drug, according to the complaint.

“Defendants plan to begin manufacturing, marketing, selling, offering to sell and/or importing Synthon’s generic glatiramer acetate product soon after FDA approval,” Teva said in the complaint. “Such conduct will constitute direct infringement.”... Read More - ... ageid/1903
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Re: Teva sues Synthon over generic Multiple Sclerosis drug

Postby its2much » Fri Apr 06, 2012 6:38 am

Is this the same lawsuit from last year? A trial began in September or October last year and then it just stopped for some unknown reason. It was a case about their patent.
User avatar
Getting to Know You...
Posts: 23
Joined: Fri Aug 05, 2011 3:00 pm

Return to Copaxone


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service